INOVIO to Participate in December Investor Conferences
Provided By PR Newswire
Last update: Nov 18, 2025
PLYMOUTH MEETING, Pa., Nov. 18, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences:
Read more at prnewswire.com
